http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105250230-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c05ad3a768edce25977a85e8e0edf45d
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-65
filingDate 2015-10-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1461d2641d2c25b2dc235de82e08cb2a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f70503512c29dee708672db862ba41c4
publicationDate 2016-01-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-105250230-A
titleOfInvention Preparing technology for tablet-type doxycycline hyclate
abstract The invention relates to a preparing technology for tablet-type doxycycline hyclate. The preparing technology includes the following steps that doxycycline hyclate is grinded into powder through a ball mill, and the powder is dissolved into water to be prepared into a solution A; ethyl cellulose is dissolved into an organic solvent to be prepared into a solution B; the solution A is slowly poured into the solution B on the stirring premise, and an emulsion C is formed after the solution A is dispersed in the solution B; gelatin is dissolved into distilled water in a water bath at the temperature of 60 DEG C to 80 DEG C to be prepared into protective fluid D, and the protective fluid D is ready for use at the constant temperature of 30 DEG C; the emulsion C is dropwise added into the protective fluid D on the stirring premise to form a solution E, the temperature of the water bath is increased from 30 DEG C to 50 DEG C, and stirring is carried out to volatize the organic solvent; then the E is subjected to suction filtration, washing and drying, white-powder-type doxycycline hyclate is obtained, and the doxycycline hyclate powder and an auxiliary material are mixed and pressed into tablets. By means of the preparing technology, the problem that an existing doxycycline hyclate preparation is low in dissolving speed in the preparing process is solved.
priorityDate 2015-10-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397383
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54684461
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451891782
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457707758
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54729367
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426260387
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID417430547
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54675779
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1140
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6344
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5360545
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54685920
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559095
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456922693
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449269991
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419534029
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24261
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559553
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID174
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24832091
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454031468

Total number of triples: 39.